Crohn's disease and smoking: Is it ever too late to quit?

Journal of Crohn's and Colitis

Volumn 7, Issue 12, 2013, Pages

  Lawrance, Ian C ^a,b   Murray, Kevin ^b   Batman, Birol ^c   Gearry, Richard B ^c   Grafton, Rachel ^d   Krishnaprasad, Krupa ^e   Andrews, Jane M ^d   Prosser, Ruth ^f   Bampton, Peter A ^f   Cooke, Sharon E ^g   Mahy, Gillian ^g   Radford Smith, Graham ^e,h,i   Croft, Anthony ^h   Hanigan, Katherine ^e  

^a FREMANTLE HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d ROYAL ADELAIDE HOSPITAL   (Australia)

^e QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^f FLINDERS MEDICAL CENTRE   (Australia)

^g TOWNSVILLE HOSPITAL   (Australia)

^h ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

ⁱ UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Crohn's disease; Disease progression; Smoking; Surgery

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; METHOTREXATE;

ABDOMINAL SURGERY; ADOLESCENT; ADULT; ARTICLE; CROHN DISEASE; DISEASE COURSE; DISEASE DURATION; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; INTESTINE SURGERY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; SMOKING CESSATION;

CROHN'S DISEASE; DISEASE PROGRESSION; SMOKING; SURGERY;

ADOLESCENT; ADULT; ANUS DISEASES; COLITIS; CROHN DISEASE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; ILEITIS; IMMUNOSUPPRESSIVE AGENTS; MALE; REOPERATION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SMOKING; SMOKING CESSATION; STEROIDS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84887605797     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.05.007     Document Type: Article

References (18)

1. Mahid S.S., Minor K.S., Soto R.E., Hornung C.A., Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 2006, 81:1462-1471.
2. Carbonnel F., Jantchou P., Monnet E., Cosnes J. Environmental risk factors in Crohn's disease and ulcerative colitis: an update. Gastroenterol Clin Biol 2009, 33(Suppl. 3):S145-S157.
3. Cosnes J., Carbonnel F., Carrat F., Beaugerie L., Cattan S., Gendre J. Effects of current and former cigarette smoking on the clinical course of Crohn's disease. Aliment Pharmacol Ther 1999, 13:1403-1411.
4. Louis E., Michel V., Hugot J.P., Reenaers C., Fontaine F., Delforge M., et al. Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut 2003, 52:552-557.
5. Breuer-Katschinski B.D., Hollander N., Goebell H. Effect of cigarette smoking on the course of Crohn's disease. Eur J Gastroenterol Hepatol 1996, 8:225-228.
6. Calkins B.M. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989, 34:1841-1854.
7. Cottone M., Rosselli M., Orlando A., Oliva L., Puleo A., Cappello M., et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994, 106:643-648.
8. Nunes T., Etchevers M.J., Merino O., Gallego S., Garcia-Sanchez V., Marin-Jimenez I., et al. High smoking cessation rate in Crohn's disease patients after physician advice - the TABACROHN study. J Crohns Colitis 2013 Apr 1, 7(3):202-207.
9. Cosnes J., Beaugerie L., Carbonnel F., Gendre J.P. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology 2001, 120:1093-1099.
10. Silverberg M., Satsangi J., Ahmad T., Arnott I., Bernstein C., Brant S. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19:5-36.
11. Lennard-Jones J. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989, 170:2-6.
12. Lawrance I.C., Maxwell L., Doe W. Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease. Inflamm Bowel Dis 2001, 7:226-236.
13. Lawrance I.C., Maxwell L., Doe W. Inflammation location, but not type, determines the increase in TGF-beta1 and IGF-1 expression and collagen deposition in IBD intestine. Inflamm Bowel Dis 2001, 7:16-26.
14. Harper P.H., Fazio V.W., Lavery I.C., Jagelman D.G., Weakley F.L., Farmer R.G., et al. The long-term outcome in Crohn's disease. Dis Colon Rectum 1987, 30:174-179.
15. Rieder F., Lawrance I.C., Leite A., Sans M. Predictors of fibrostenotic Crohn's disease. Inflamm Bowel Dis 2011, 17:2000-2007.
16. Cerqueira R.M., Lago P.M. Clinical factors predictive of Crohn's disease complications and surgery. Eur J Gastroenterol Hepatol 2013, 25:129-134.
17. Lazarev M., Huang C., Bitton A., Cho J.H., Duerr R.H., McGovern D.P., et al. Relationship between proximal Crohn's disease location and disease behavior and surgery: a cross-sectional study of the IBD Genetics Consortium. Am J Gastroenterol 2013, 108:106-112.
18. Murray K., Heritier S., Müller S. Graphical tools for model selection in generalized linear models. Stat Med 2013 May 29, [Epub ahead of print]. 10.1002/sim.5855.